Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
-
Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update
-
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Powered by HEALWELL AI
-
Official Announcement: $DEDE, the New Dino-Themed Meme Coin on Solana Blockchain
-
AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting 2024
-
CDT Environmental Technology Investment Holdings Limited Receives Three New Utility Model Patent Allowances from the China National Intellectual Property Administration (CNIPA)
-
Fengate adds six seniors housing facilities to its U.S. healthcare and seniors housing portfolio
-
NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024
-
Dremio and VAST Data Build the First Zero Trust Data Lakehouse Platform - Sets a New Standard for Data Security and Accessibility
-
TeraWulf Announces April 2024 Production and Operations Update
-
Provectus Biopharmaceuticals Announces Notice of Allowance for U.S. Patent of Oral Administration of Rose Bengal Sodium in Hematology (Leukemia)
-
Super League Sets First Quarter 2024 Earnings Date, May 15, 2024
-
Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma
-
Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
-
Northann Corp.'s Blue11-Ocean Plastic Flooring and Wall Panels Product Wins Multiple Prestigious Awards in 2024
-
Duos Granted Comprehensive Patent for Railcar Scanning
-
Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement
-
Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended March 31, 2024 and Declaration of Distributions on Common Stock for the Months Ending July 31
-
LVT Hires Mark Cranney as Chief Revenue Officer
-
Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial
-
PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
-
Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer
-
Bebuzee’s Revolutionary Super App Will Disrupt US and European Markets
-
New York Jets Announce Multi-Year Partnership with VitaCholine®
-
College Innovation Network Celebrates Four Years of Transformative Impact on Higher Education
-
Over $25 Billion in California Farmland Transactions Analyzed in Inaugural Report
-
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
-
CALL FOR SUBMISSIONS: 2024 Hillsdale Investment Management – CFA Society Toronto Research Award
-
NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024
-
CareCloud and NJ Comprehensive Healthcare Partner for Operational Efficiency and Cost Reduction
-
FOREWARN Partners with Virginia REALTORS®
-
Alterra IOS Venture III raises $925 million, surpassing $750 million target and increasing hard cap beyond $850 million
-
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
-
Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism
-
Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024
-
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
-
Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer
-
Arbe to Participate at the Oppenheimer 9th Annual Emerging Growth Conference
-
EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
-
Optimizing Application Connections and Improving Security Posture Among Top SD-WAN Deployment Drivers
-
60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
-
CompTIA introduces new Data Advisory Council to help businesses foster data-driven culture
-
Subsea7: Subsea Integration Alliance collaboration agreement with Equinor; Commencing work on Wisting and Bay du Nord
-
Alliance Trust PLC - Net Asset Value
-
Avance Gas Holding Ltd: Invitation to Earnings Presentation for the First Quarter of 2024
-
CoreCard Corporation Reports First Quarter 2024 Results
-
Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
-
VitalHub Announces Q1 2024 Conference Call Date
-
Parker Reports Fiscal 2024 Third Quarter Results
-
Stack Capital Group Inc. Reports Q1-24 Financial Results

